JP7473960B2 - Water-soluble preparations containing highly unsaturated fatty acids - Google Patents
Water-soluble preparations containing highly unsaturated fatty acids Download PDFInfo
- Publication number
- JP7473960B2 JP7473960B2 JP2020132805A JP2020132805A JP7473960B2 JP 7473960 B2 JP7473960 B2 JP 7473960B2 JP 2020132805 A JP2020132805 A JP 2020132805A JP 2020132805 A JP2020132805 A JP 2020132805A JP 7473960 B2 JP7473960 B2 JP 7473960B2
- Authority
- JP
- Japan
- Prior art keywords
- unsaturated fatty
- highly unsaturated
- acid
- soluble
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims description 64
- 150000004670 unsaturated fatty acids Chemical class 0.000 title claims description 64
- 238000002360 preparation method Methods 0.000 title claims description 51
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 39
- 239000003963 antioxidant agent Substances 0.000 claims description 38
- 235000006708 antioxidants Nutrition 0.000 claims description 38
- 230000003078 antioxidant effect Effects 0.000 claims description 33
- 235000010323 ascorbic acid Nutrition 0.000 claims description 18
- 239000011668 ascorbic acid Substances 0.000 claims description 17
- 229960005070 ascorbic acid Drugs 0.000 claims description 17
- -1 gallic acid fatty acid ester Chemical class 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 13
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 10
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 10
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 10
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 10
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000839 emulsion Substances 0.000 claims description 10
- 235000013824 polyphenols Nutrition 0.000 claims description 10
- 239000011732 tocopherol Substances 0.000 claims description 10
- 229930003799 tocopherol Natural products 0.000 claims description 10
- 230000002292 Radical scavenging effect Effects 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 9
- 235000010350 erythorbic acid Nutrition 0.000 claims description 9
- 235000019197 fats Nutrition 0.000 claims description 9
- 229930195729 fatty acid Natural products 0.000 claims description 9
- 239000000194 fatty acid Substances 0.000 claims description 9
- 230000033116 oxidation-reduction process Effects 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 235000010384 tocopherol Nutrition 0.000 claims description 9
- 229960001295 tocopherol Drugs 0.000 claims description 9
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 9
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims description 8
- 239000004318 erythorbic acid Substances 0.000 claims description 8
- 230000001747 exhibiting effect Effects 0.000 claims description 8
- 229940026239 isoascorbic acid Drugs 0.000 claims description 8
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 5
- 229960004488 linolenic acid Drugs 0.000 claims description 5
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims description 4
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000005487 catechin Nutrition 0.000 claims description 4
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 4
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 3
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 3
- 235000010208 anthocyanin Nutrition 0.000 claims description 3
- 229930002877 anthocyanin Natural products 0.000 claims description 3
- 239000004410 anthocyanin Substances 0.000 claims description 3
- 150000004636 anthocyanins Chemical class 0.000 claims description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 2
- 150000001765 catechin Chemical class 0.000 claims description 2
- 229940074393 chlorogenic acid Drugs 0.000 claims description 2
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 2
- 235000004515 gallic acid Nutrition 0.000 claims description 2
- 229940074391 gallic acid Drugs 0.000 claims description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 claims description 2
- 229940035936 ubiquinone Drugs 0.000 claims description 2
- 241001122767 Theaceae Species 0.000 claims 1
- 239000003921 oil Substances 0.000 description 23
- 235000019198 oils Nutrition 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 11
- 235000014593 oils and fats Nutrition 0.000 description 11
- 235000013305 food Nutrition 0.000 description 10
- 239000003925 fat Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 8
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 6
- 235000013373 food additive Nutrition 0.000 description 6
- 239000002778 food additive Substances 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 235000021067 refined food Nutrition 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 4
- 235000021342 arachidonic acid Nutrition 0.000 description 4
- 229940114079 arachidonic acid Drugs 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 229940067631 phospholipid Drugs 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 229920000223 polyglycerol Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- AHANXAKGNAKFSK-PDBXOOCHSA-N all-cis-icosa-11,14,17-trienoic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCCCC(O)=O AHANXAKGNAKFSK-PDBXOOCHSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 2
- PRHHYVQTPBEDFE-UHFFFAOYSA-N eicosatrienoic acid Natural products CCCCCC=CCC=CCCCCC=CCCCC(O)=O PRHHYVQTPBEDFE-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 2
- 229960002733 gamolenic acid Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940055416 blueberry extract Drugs 0.000 description 1
- 235000019216 blueberry extract Nutrition 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 238000003918 potentiometric titration Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 150000003669 ubiquinones Chemical class 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- JLQFVGYYVXALAG-CFEVTAHFSA-N yasmin 28 Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 JLQFVGYYVXALAG-CFEVTAHFSA-N 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
- Cosmetics (AREA)
- Fats And Perfumes (AREA)
Description
本発明は、高度不飽和脂肪酸、又は高度不飽和脂肪酸を含有する油脂類を酸化に対して安定的に水溶化し、水を含む加工食品等に添加、配合することができる高度不飽和脂肪酸含有水溶性製剤に関する。 The present invention relates to a water-soluble preparation containing highly unsaturated fatty acids that can be added or blended into processed foods containing water by solubility in water of highly unsaturated fatty acids or oils and fats containing highly unsaturated fatty acids in a stable manner against oxidation.
エイコサペンタエン酸(EPA)、ドコサヘキサエン酸(DHA)、アラキドン酸(ARA)、α-リノレン酸、γ-リノレン酸等の高度不飽和脂肪酸は動脈硬化予防や脳機能の活性化等の生体調節機能に関する報告が数多く有り、その生理機能が注目されている。これらの高度不飽和脂肪酸は遊離脂肪酸の形態のみならずアルキルエステル、トリアシルグリセロール、リン脂質、糖脂質等種々の油脂形態で生体中に存在するが、一般的には魚油やシソ油、アマニ油等の植物油といったトリアシルグリセロールの形態の油脂として供給される。一方、飲料をはじめとする加工食品には多量の水分が含まれるため、油脂類はそのままの状態での配合は難しく、乳化・分散等の製剤加工が必要で、加工された油脂含有製剤は乳液や粉末等の製剤形態が存在する。 There have been many reports on the biological regulation functions of polyunsaturated fatty acids such as eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (ARA), α-linolenic acid, and γ-linolenic acid, including the prevention of arteriosclerosis and activation of brain function, and their physiological functions have been attracting attention. These polyunsaturated fatty acids exist in the body not only in the form of free fatty acids but also in various oil and fat forms such as alkyl esters, triacylglycerols, phospholipids, and glycolipids, but are generally supplied as oil and fat in the form of triacylglycerols such as fish oil, perilla oil, and vegetable oils such as linseed oil. On the other hand, processed foods such as beverages contain a large amount of water, making it difficult to mix oils and fats in their original state, and preparation processing such as emulsification and dispersion is required, and processed oil-containing preparations are available in the form of emulsions, powders, and other formulations.
一方、高度不飽和脂肪酸は不飽和結合が多いため酸化に対して不安定であり、製剤加工や保存中に酸化変性を受け、臭気劣化や着色等の品質低下が発生するとう問題を有する。一般的に油脂の酸化防止にはトコフェロールやアスコルビン酸、ブチルヒドロキシアニソール(BHA)やブチルヒドロキシトルエン(BHT)といった酸化防止剤の利用が一般的ではあるが、不飽和結合が多い高度不飽和脂肪酸含有油脂への単純な添加では十分な効果を得ることができず、さらに乳化物等の極性が異なる化合物の製剤の系では、均一系とは異なる酸化防止作用を示すことも報告されている(非特許文献1)。 On the other hand, highly unsaturated fatty acids are unstable to oxidation due to the large number of unsaturated bonds, and are subject to oxidative modification during formulation processing and storage, resulting in quality degradation such as odor deterioration and discoloration. Generally, antioxidants such as tocopherol, ascorbic acid, butyl hydroxyanisole (BHA), and butyl hydroxytoluene (BHT) are used to prevent the oxidation of oils and fats, but simply adding them to oils and fats containing highly unsaturated fatty acids, which have many unsaturated bonds, is not effective enough, and it has also been reported that formulations of compounds with different polarities, such as emulsions, show antioxidant effects different from those in homogeneous systems (Non-Patent Document 1).
高度不飽和脂肪酸を含む水溶化製剤の安定化には、これまで種々の方法が報告されており、例えば油脂と魚介エキスにトコフェロール、リン脂質、アスコルビン酸等を添加しポリグリセリン脂肪酸エステル等の乳化剤で乳化する方法(特許文献1)、水相中にアスコルビン酸、エリソルビン酸等の水溶性抗酸化剤を添加し、油相中にゴマ油、アスコルビン酸エステル、トコフェロール等の油溶性抗酸化剤含有成分を添加し乳化する方法(特許文献2)、アスコルビン酸、カテキン等の酸化防止剤と多価アルコールを添加し、HLB10以上のポリグリセリン脂肪酸エステルと蔗糖脂肪酸エステル、レシチンを用いて乳化物を得る方法(特許文献3)、モノグリセリドを含む高度不飽和脂肪酸にトコフェロールやリン脂質を加え、さらにカゼインや大豆タンパク等を加えた乳化物を乾燥させることで得られた粉体(特許文献4)、高度不飽和脂肪酸含有油脂にミセル状カゼインと水溶性酸化防止剤、油溶性酸化防止剤、トレハロース等の糖類とともに乳化剤を用いて乳化後、乾燥させて粉体を得る方法(特許文献5)、ゴマの抗酸化成分をアスコルビン酸又はアスコルビン酸エステルとともに配合する方法(特許文献6)などが開示されているが、いずれも抗酸化成分の種類や配合量のバランスの面で酸化安定性が十分とは言えない。 Various methods have been reported for stabilizing water-soluble preparations containing highly unsaturated fatty acids. For example, there is a method in which tocopherol, phospholipids, ascorbic acid, etc. are added to oils and seafood extracts and emulsified with an emulsifier such as polyglycerol fatty acid ester (Patent Document 1), a method in which a water-soluble antioxidant such as ascorbic acid or erythorbic acid is added to the aqueous phase, and an oil-soluble antioxidant-containing component such as sesame oil, ascorbic acid ester, tocopherol, etc. is added to the oil phase and emulsified (Patent Document 2), and a method in which an antioxidant such as ascorbic acid or catechin and a polyhydric alcohol are added, and a milk-soluble preparation containing a polyglycerol fatty acid ester with an HLB of 10 or more, a sucrose fatty acid ester, and lecithin is used to emulsify the oil phase. Disclosed are a method for obtaining an emulsion (Patent Document 3), a powder obtained by adding tocopherol or phospholipids to highly unsaturated fatty acids including monoglycerides, and then drying the emulsion to which casein or soy protein or the like is added (Patent Document 4), a method for emulsifying oils and fats containing highly unsaturated fatty acids with micellar casein, a water-soluble antioxidant, an oil-soluble antioxidant, sugars such as trehalose, and an emulsifier, and then drying the resulting powder (Patent Document 5), and a method for blending antioxidant components of sesame with ascorbic acid or an ascorbic acid ester (Patent Document 6). However, none of these methods can be said to have sufficient oxidation stability in terms of the balance of the types and amounts of antioxidant components blended.
一方、ゼラチン架橋酵素を用いて高度不飽和脂肪酸をマイクロカプセル化して安定な粉体を得る技術も開示されているが(特許文献7)、架橋化されたマイクロカプセルは水に不溶なため、水分が多い食品へ応用することは難しいという課題を有する。 On the other hand, a technology has been disclosed in which highly unsaturated fatty acids are microencapsulated using a gelatin cross-linking enzyme to obtain a stable powder (Patent Document 7), but the cross-linked microcapsules are insoluble in water, making it difficult to apply this to foods that contain a lot of moisture.
本発明の目的は、水溶性を示さず、さらに酸化安定性が低い高度不飽和脂肪酸又は高度不飽和脂肪酸を含有する油脂を安定的に水溶化し、水を含む加工食品等に対して安定的に配合しうる高度不飽和脂肪酸含有水溶性製剤を提供することである。 The object of the present invention is to provide a water-soluble preparation containing highly unsaturated fatty acids that is not water-soluble and has low oxidation stability, and that can stably solubilize highly unsaturated fatty acids or oils and fats containing highly unsaturated fatty acids, and can be stably blended with processed foods and the like that contain water.
本発明者らは、(A)高度不飽和脂肪酸又は高度不飽和脂肪酸を含有する油脂、(B)(b1)フェノール性水素を有する油溶性のラジカル捕捉型酸化防止剤及び/又は(b2)酸化-還元型を示す油溶性の酸化防止剤、(C)(c1)フェノール性水素を有する水溶性のラジカル捕捉型酸化防止剤及び/又は(c2)酸化-還元型を示す水溶性の酸化防止剤を含有し、水に対して良好な溶解性を示す乳液もしくは粉体製剤であって、(A)の含有量が5質量%~60質量%、(B)及び(C)の合計含有量が0.01質量%~10質量%であり、(B)/(C)の比率が0.2~5であり、((b1)+(c1))/((b2)+(c2))の比率が0.2~5とすることで、高度不飽和脂肪酸又は高度不飽和脂肪酸を含有する油脂を水を含む加工食品等に対して安定的配合しうることを見出し、本発明を完成するに至った。 The present inventors have discovered that an emulsion or powder preparation containing (A) highly unsaturated fatty acids or oils and fats containing highly unsaturated fatty acids, (B) (b1) an oil-soluble radical scavenging antioxidant having phenolic hydrogen and/or (b2) an oil-soluble antioxidant exhibiting oxidation-reduction type, (C) (c1) a water-soluble radical scavenging antioxidant having phenolic hydrogen and/or (c2) a water-soluble antioxidant exhibiting oxidation-reduction type, and exhibiting good solubility in water, in which the content of (A) is 5% to 60% by mass, the total content of (B) and (C) is 0.01% to 10% by mass, the ratio of (B)/(C) is 0.2 to 5, and the ratio of ((b1)+(c1))/((b2)+(c2)) is 0.2 to 5, allows highly unsaturated fatty acids or oils and fats containing highly unsaturated fatty acids to be stably blended with processed foods and the like containing water, thereby completing the present invention.
即ち、本発明は以下のとおりである。
[1] (A)高度不飽和脂肪酸又は高度不飽和脂肪酸を含有する油脂と、
(B)(b1)フェノール性水素を有する油溶性のラジカル捕捉型酸化防止剤及び/又は(b2)酸化-還元型を示す油溶性の酸化防止剤と、
(C)(c1)フェノール性水素を有する水溶性のラジカル捕捉型酸化防止剤及び/又は(c2)酸化-還元型を示す水溶性の酸化防止剤(但し、アスコルビン酸、エリソルビン酸を除く。)とを含有する高度不飽和脂肪酸含有水溶性製剤であって、
(A)の含有量が5質量%~60質量%、(B)及び(C)の合計含有量が0.01質量%~10質量%であり、(B)/(C)の比率が0.2~5であり、((b1)+(c1))/((b2)+(c2))の比率が0.2~5であることを特徴とする高度不飽和脂肪酸含有水溶性製剤。
[2] (b1)が、トコフェロール、没食子酸脂肪酸エステル、BHA、BHTのうちの1種又は2種以上である前記[1]記載の高度不飽和脂肪酸含有水溶性製剤。
[3] (b2)が、アスコルビン酸脂肪酸エステル、ユビキノンのうちの1種又は2種以上である前記[1]又は[2]記載の高度不飽和脂肪酸含有水溶性製剤。
[4] (c1)が、茶カテキン、アントシアニン、クロロゲン酸のうちの1種又は2種以上である前記[1]~[3]のいずれかに記載の高度不飽和脂肪酸含有水溶性製剤。
[5] (c2)が、アスコルビン酸金属塩、エリソルビン酸金属塩のうちの1種又は2種以上である前記[1]~[4]のいずれかに記載の高度不飽和脂肪酸含有水溶性製剤。
[6] (A)の高度不飽和脂肪酸が、エイコサペンタエン酸(EPA)、ドコサヘキサエン酸(DHA)、α-リノレン酸のいずれかを含む前記[1]~[5]のいずれかに記載の高度不飽和脂肪酸含有水溶性製剤。
[7] 前記製剤の形態が乳液である前記[1]~[6]のいずれかに記載の高度不飽和脂肪酸含有水溶性製剤。
[8] 前記製剤の形態が粉体である前記[1]~[6]のいずれかに記載の高度不飽和脂肪酸含有水溶性製剤。
That is, the present invention is as follows.
[1] (A) a highly unsaturated fatty acid or an oil or fat containing a highly unsaturated fatty acid;
(B) (b1) an oil-soluble radical scavenging antioxidant having a phenolic hydrogen and/or (b2) an oil-soluble antioxidant exhibiting an oxidation-reduction type,
(C) A highly unsaturated fatty acid-containing water-soluble preparation containing (c1) a water-soluble radical-scavenging antioxidant having a phenolic hydrogen atom and/or (c2) a water-soluble antioxidant exhibiting an oxidation-reduction type (excluding ascorbic acid and erythorbic acid),
A water-soluble preparation containing highly unsaturated fatty acids, characterized in that the content of (A) is 5% by mass to 60% by mass, the total content of (B) and (C) is 0.01% by mass to 10% by mass, the ratio of (B)/(C) is 0.2 to 5, and the ratio of ((b1)+(c1))/((b2)+(c2)) is 0.2 to 5.
[2] The highly unsaturated fatty acid-containing water-soluble preparation according to the above [1], wherein (b1) is one or more of tocopherol, gallic acid fatty acid ester, BHA, and BHT.
[3] The highly unsaturated fatty acid-containing water-soluble preparation according to the above [1] or [2], wherein (b2) is one or more of an ascorbic acid fatty acid ester and ubiquinone.
[4] The water-soluble preparation containing highly unsaturated fatty acids according to any one of [1] to [3] above, wherein (c1) is one or more of tea catechins, anthocyanins, and chlorogenic acid.
[5] The water-soluble preparation containing highly unsaturated fatty acids according to any one of [1] to [4], wherein (c2) is one or more of metal salts of ascorbic acid and metal salts of erythorbic acid.
[6] The highly unsaturated fatty acid-containing water-soluble preparation according to any one of [1] to [5] above, wherein the highly unsaturated fatty acid (A) includes any one of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and α-linolenic acid.
[7] The highly unsaturated fatty acid-containing water-soluble preparation according to any one of [1] to [6], wherein the preparation is in the form of an emulsion.
[8] The highly unsaturated fatty acid-containing water-soluble preparation according to any one of [1] to [6], wherein the preparation is in the form of a powder.
本発明は、従来の高度不飽和脂肪酸含有水溶性製剤化技術と比較して酸化安定性や水を含む加工食品中での配合安定性に優れており、水を含む加工食品分野において高度不飽和脂肪酸又は高度不飽和脂肪酸を含有する油脂を効果的に添加、配合しうることを特徴とする新規技術である。 The present invention is a novel technology that has superior oxidation stability and blending stability in processed foods containing water compared to conventional water-soluble formulation technologies containing highly unsaturated fatty acids, and is characterized by the ability to effectively add and blend highly unsaturated fatty acids or oils and fats containing highly unsaturated fatty acids in the field of processed foods containing water.
本発明に用いられる(A)高度不飽和脂肪酸又は高度不飽和脂肪酸を含有する油脂は、食品又は食品添加物として用いられるものであればその種類に特に限定はないが、例えば高度不飽和脂肪酸としては、エイコサペンタエン酸(EPA)、ドコサヘキサエン酸(DHA)、アラキドン酸(ARA)、α-リノレン酸、γ-リノレン、エイコサテトラエン酸(ETA)、エイコサトリエン酸(ETE)、リノール酸、ステアリドン酸(SDA)などが挙げられ、油脂としては、トリアシルグリセロール、リン脂質、糖脂質などが挙げられ、これらを1種又は2種以上用いることができる。なお、高度不飽和脂肪酸とは、不飽和結合を2つ以上持つ脂肪酸をいう。 The (A) highly unsaturated fatty acid or fats and oils containing highly unsaturated fatty acids used in the present invention are not particularly limited in type as long as they are used as foods or food additives. For example, highly unsaturated fatty acids include eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (ARA), α-linolenic acid, γ-linolenic acid, eicosatetraenoic acid (ETA), eicosatrienoic acid (ETE), linoleic acid, and stearidonic acid (SDA). Fat and oil include triacylglycerol, phospholipid, and glycolipid, and one or more of these can be used. Note that highly unsaturated fatty acids refer to fatty acids having two or more unsaturated bonds.
本発明の高度不飽和脂肪酸含有水溶性製剤における上記(A)高度不飽和脂肪酸又は高度不飽和脂肪酸を含有する油脂の含有量は、本発明の高度不飽和脂肪酸含有水溶性製剤全体に対して、5質量%~60質量%、好ましくは7質量%~50質量%、さらに好ましくは10質量%~40質量%である。配合量が5質量%未満であると多くの配合量が必要となり経済性に問題が生じ、また60質量%を超える場合は分離や油浮き等の製剤の安定性に問題が生じ好ましくない。 The content of the (A) highly unsaturated fatty acid or oils and fats containing highly unsaturated fatty acids in the highly unsaturated fatty acid-containing water-soluble preparation of the present invention is 5% by mass to 60% by mass, preferably 7% by mass to 50% by mass, and more preferably 10% by mass to 40% by mass, based on the entire highly unsaturated fatty acid-containing water-soluble preparation of the present invention. If the blending amount is less than 5% by mass, a large blending amount is required, which causes problems in terms of economy, and if it exceeds 60% by mass, problems with the stability of the preparation, such as separation and oil floating, are undesirable.
本発明に用いられる(b1)フェノール性水素を有する油溶性のラジカル捕捉型酸化防止剤は、食品又は食品添加物として用いられるものであればその種類に特に限定はなく、例えばトコフェロール類、没食子酸エステル類、BHA(ブチルヒドロキシアニソール)、BHT(ジブチルヒドロキシトルエン)、油溶性カテキン等が挙げられ、これらを1種又は2種以上用いることができる。 The oil-soluble radical scavenging antioxidant having a phenolic hydrogen (b1) used in the present invention is not particularly limited in type as long as it is used as a food or food additive, and examples thereof include tocopherols, gallic acid esters, BHA (butyl hydroxyanisole), BHT (dibutyl hydroxytoluene), oil-soluble catechin, etc., and one or more of these can be used.
本発明に用いられる(b2)酸化-還元型を示す油溶性の酸化防止剤は、食品又は食品添加物として用いられるものであればその種類に特に限定はなく、ユビキノン類、アスコルビン酸エステル類等が挙げられ、これらを1種又は2種以上用いることができる。 The type of the oil-soluble antioxidant (b2) showing an oxidation-reduction type used in the present invention is not particularly limited as long as it is used as a food or food additive, and examples of such antioxidants include ubiquinones and ascorbic acid esters, and one or more of these can be used.
本発明に用いられる(c1)フェノール性水素を有する水溶性のラジカル捕捉型酸化防止剤は、食品又は食品添加物として用いられるものであればその種類に特に限定はなく、アントシアニン類、茶抽出物、コーヒー抽出物等の水溶性ポリフェノール類が挙げられ、これらを1種又は2種以上用いることができる。 The water-soluble radical scavenging antioxidant having a phenolic hydrogen (c1) used in the present invention is not particularly limited in type as long as it is used as a food or food additive, and examples of the antioxidant include water-soluble polyphenols such as anthocyanins, tea extracts, and coffee extracts, and one or more of these can be used.
本発明に用いられる(c2)酸化-還元型を示す水溶性の酸化防止剤は、食品又は食品添加物として用いられるものであればその種類に特に限定はなく、アスコルビン酸類及びその塩類、エリソルビン酸類及びその塩類等、特にアスコルビン酸金属塩、エリソルビン酸金属塩が挙げられ、これらを1種又は2種以上用いることができる。但し、アスコルビン酸、エリソルビン酸は、過酸化物価を上昇させることになるため、上記酸化防止剤から除くことが好ましい。 The water-soluble oxidation-reduction type antioxidant (c2) used in the present invention is not particularly limited in type as long as it is used as a food or food additive, and examples thereof include ascorbic acids and their salts, erythorbic acids and their salts, and in particular metal salts of ascorbic acid and metal salts of erythorbic acid, and one or more of these can be used. However, ascorbic acid and erythorbic acid increase the peroxide value, it is preferable to exclude them from the above antioxidants.
上記(b1)と(b2)の合計を(B)、同じく(c1)と(c2)の合計を(C)とするとき、本発明に用いられる酸化防止剤の合計量である(B)及び(C)の合計量は、本発明の高度不飽和脂肪酸含有水溶性製剤全体に対して、好ましくは0.01質量%~10質量%であり、より好ましくは0.03質量%~8質量%、さらに好ましくは0.05質量%~6質量%である。配合量が0.01質量%未満であると酸化防止効果が十分ではなく、また10質量%を超える場合は製剤全体のバランスが崩れ分離の発生や着色等の不具合が生じ好ましくない。 When the sum of (b1) and (b2) above is (B), and the sum of (c1) and (c2) is (C), the total amount of (B) and (C) used in the present invention is preferably 0.01% to 10% by mass, more preferably 0.03% to 8% by mass, and even more preferably 0.05% to 6% by mass, based on the entire highly unsaturated fatty acid-containing water-soluble preparation of the present invention. If the amount is less than 0.01% by mass, the antioxidant effect is insufficient, and if it exceeds 10% by mass, the balance of the entire preparation is lost, causing problems such as separation and coloring, which is undesirable.
本発明に用いられる(B)と(C)の比率である(B)/(C)は、好ましくは0.2~5であり、より好ましくは0.3~4であり、さらに好ましくは0.4~3である。前記比率が0.2未満又は5を超えると十分な酸化防止効果が得られず好ましくない。 The ratio of (B) to (C) used in the present invention, (B)/(C), is preferably 0.2 to 5, more preferably 0.3 to 4, and even more preferably 0.4 to 3. If the ratio is less than 0.2 or more than 5, a sufficient antioxidant effect cannot be obtained, which is not preferable.
本発明に用いられる((b1)+(c1))/((b2)+(c2))の比率は、好ましくは0.2~5であり、より好ましくは0.3~4であり、さらに好ましくは0.4~3である。前記比率が0.2未満又は5を超えると十分な酸化防止効果が得られず好ましくない。 The ratio ((b1)+(c1))/((b2)+(c2)) used in the present invention is preferably 0.2 to 5, more preferably 0.3 to 4, and even more preferably 0.4 to 3. If the ratio is less than 0.2 or exceeds 5, a sufficient antioxidant effect cannot be obtained, which is not preferred.
本発明の高度不飽和脂肪酸含有水溶性製剤には、本発明の効果を損なわない限り、公知の食品中に用いられる乳化剤を用いることができる。例えばポリグリセリンエステル類、モノグリセリンエステル類、シュガーエステル類、ソルビタンエステル類、レシチン類、増粘多糖類などが挙げられ、これらは単独あるいは2 種以上を組み合わせて添加することができる。 In the highly unsaturated fatty acid-containing water-soluble preparation of the present invention, emulsifiers used in known foods can be used as long as they do not impair the effects of the present invention. Examples include polyglycerol esters, monoglycerol esters, sugar esters, sorbitan esters, lecithins, thickening polysaccharides, etc., which can be added alone or in combination of two or more kinds.
本発明の高度不飽和脂肪酸含有水溶性製剤には、本発明の効果を損なわない限り、公知の食品又は食品添加物原料を配合することができる。例えば、基剤成分として、油分、水分、アルコール類、ワックス類、賦形剤として、糖類、多糖類、デンプン類、添加成分として、有機酸類、無機塩類、防腐剤、香料、キレート剤、比重調整剤、粘度調整剤等を配合することができる。 The highly unsaturated fatty acid-containing water-soluble preparation of the present invention can be blended with known food or food additive raw materials as long as the effects of the present invention are not impaired. For example, base components such as oils, water, alcohols, and waxes can be blended, excipients such as sugars, polysaccharides, and starches can be blended, and additive components such as organic acids, inorganic salts, preservatives, flavorings, chelating agents, specific gravity adjusters, and viscosity adjusters can be blended.
本発明の高度不飽和脂肪酸含有水溶性製剤の製造のために用いる機械類は特に限定されるものではなく、ミキサー、アジテーター、ディスパーサー、ホモミキサー、ホモジナイザー、高圧ホモジナイザー、超高圧ホモジナイザー、ボールミル、コロイドミル、遊星型ミル、湿式OBミル、回転式粉砕機、混練機、ニーダー、スプレードライヤー、真空乾燥機、フリーズドライヤー、振動篩等の機械を単独又は組み合わせて使用することができる。 The machines used for producing the highly unsaturated fatty acid-containing water-soluble preparation of the present invention are not particularly limited, and machines such as mixers, agitators, dispersers, homomixers, homogenizers, high-pressure homogenizers, ultra-high-pressure homogenizers, ball mills, colloid mills, planetary mills, wet OB mills, rotary grinders, kneaders, kneaders, spray dryers, vacuum dryers, freeze dryers, and vibrating sieves can be used alone or in combination.
本発明の高度不飽和脂肪酸含有水溶性製剤の形態としては、本発明の効果を損なわない限り特に限定されず、通常の調製法では液状製剤の形態をとることが多いが、賦形剤を混合し、噴霧乾燥や真空乾燥、凍結乾燥等の処理を行い紛体化して利用することもできる。 The form of the highly unsaturated fatty acid-containing water-soluble preparation of the present invention is not particularly limited as long as it does not impair the effects of the present invention. In typical preparation methods, the preparation is often in the form of a liquid preparation, but it can also be used after mixing with an excipient and powdering it by spray drying, vacuum drying, freeze drying, or other processing.
次に実施例を挙げて本発明を詳細に説明するが、本発明はこれらの実施例に限定されるものではない。 The present invention will now be described in detail with reference to examples, but the present invention is not limited to these examples.
本実施例、比較例では、DHA含有油脂として、DHAアルガルオイル(BASF社製)、EPA含有油脂として、EPA(マルハニチロ社製)、α-リノレン酸含有油脂として、アマニ油(日清製油社製)、トコフェロールとして、イーミックス70(三菱ケミカルフーズ社製)、没食子酸プロピル(富士化学工業社製)、BHA、BHT(以上、日揮ユニバーサル社製)、アスコルビン酸パルミテート、アスコルビン酸ナトリウム、アスコルビン酸、エリソルビン酸ナトリウム、コエンザイムQ10(以上、渡辺ケミカル社製)、茶カテキン、ブルーベリー抽出物、コーヒー抽出物(以上、常盤植物化学社製)を用い、トコフェロールに関しては原料のトコフェロール濃度と原料油脂中の含有濃度を換算して添加し、表中の添加量は換算合計添加量で表した。 In this embodiment and comparative example, DHA algal oil (manufactured by BASF) was used as the DHA-containing oil, EPA (manufactured by Maruha Nichiro) was used as the EPA-containing oil, linseed oil (manufactured by Nisshin Oil Mills) was used as the α-linolenic acid-containing oil, and Emix 70 (manufactured by Mitsubishi Chemical Foods), propyl gallate (manufactured by Fuji Chemical Industry Co., Ltd.), BHA, BHT (all manufactured by Nikki Universal Co., Ltd.), ascorbyl palmitate, sodium ascorbate, ascorbic acid, sodium erythorbate, coenzyme Q10 (all manufactured by Watanabe Chemical Co., Ltd.), tea catechin, blueberry extract, coffee extract (all manufactured by Tokiwa Phytochemical Co., Ltd.) were used as the tocopherol. The tocopherol was added by converting the tocopherol concentration of the raw material and the concentration contained in the raw material oil, and the amount added in the table is shown as the converted total amount added.
[調製例1:高度不飽和脂肪酸含有乳液の調製(実施例1~5、比較例1~3)]
40質量%のグリセリン(坂本薬品社製)、5質量%のサンソフトQ-17S(太陽化学社製)を80℃に加熱後、ホモミキサーを用いて6000rpmにて5分間均一化処理し、40℃に冷却後、5質量%のココナードMT(花王社製)と表1記載の(A)の高度不飽和脂肪酸含有油脂と(B)の酸化防止剤を添加した。なお、脂肪酸エステルの前記酸化防止剤は少量のエタノールに溶解し、その他の前記酸化防止剤はココナードMTに溶解して添加した。その後ホモミキサーを用いて40℃で6000rpmにて10分間均一化処理し、さらに(C)の酸化防止剤と残部の水を添加して40℃にてホモミキサーで6000rpm、10分間均一化処理を行い、実施例1~5、比較例1~3の乳液を得た。
[Preparation Example 1: Preparation of highly unsaturated fatty acid-containing emulsion (Examples 1 to 5, Comparative Examples 1 to 3)]
40% by mass of glycerin (manufactured by Sakamoto Yakuhin Co., Ltd.) and 5% by mass of Sunsoft Q-17S (manufactured by Taiyo Kagaku Co., Ltd.) were heated to 80°C, and homogenized for 5 minutes at 6000 rpm using a homomixer. After cooling to 40°C, 5% by mass of Coconard MT (manufactured by Kao Corporation) and the highly unsaturated fatty acid-containing oils and fats (A) and antioxidants (B) shown in Table 1 were added. The antioxidants of fatty acid esters were dissolved in a small amount of ethanol, and the other antioxidants were dissolved in Coconard MT and added. Then, the mixture was homogenized for 10 minutes at 6000 rpm using a homomixer at 40°C, and the antioxidant (C) and the remaining water were added, and the mixture was homogenized for 10 minutes at 6000 rpm using a homomixer at 40°C to obtain emulsions of Examples 1 to 5 and Comparative Examples 1 to 3.
[調製例2:高度不飽和脂肪酸含有粉体の調製(実施例6~8、比較例4、5)]
表2に記載の(A)の高度不飽和脂肪酸含有油脂と少量のエタノールに溶解した(B)の酸化防止剤と10質量%のトレハロースと(C)の酸化防止剤、残部の還元麦芽糖水飴(渡辺ケミカル社製)を加え、ニーダーを用いて4時間以上混練し、その後60℃にて3日間減圧乾燥し、回転粉砕機にて粉砕し30メッシュの篩にて分別して実施例6~8、比較例4、5の粉体を得た。
[Preparation Example 2: Preparation of highly unsaturated fatty acid-containing powder (Examples 6 to 8, Comparative Examples 4 and 5)]
The oil or fat containing highly unsaturated fatty acids (A) shown in Table 2, the antioxidant (B) dissolved in a small amount of ethanol, 10% by mass of trehalose and the antioxidant (C), and the remainder of reduced maltose syrup (manufactured by Watanabe Chemical Co., Ltd.) were added and kneaded using a kneader for 4 hours or more, and then dried under reduced pressure at 60°C for 3 days. The mixture was then pulverized using a rotary pulverizer and separated using a 30 mesh sieve to obtain powders of Examples 6 to 8 and Comparative Examples 4 and 5.
[調製例3:高度不飽和脂肪酸含有粉体の調製(実施例9~10、参考例1、比較例6)]
12質量%のアラビックコールSS(三栄薬品貿易社製)、9質量%のパインデックス#2(松谷化学社製)と表2に記載の(A)の高度不飽和脂肪酸含有油脂と酸化防止剤を除いた残部の水を80℃に加熱後、ホモミキサーを用いて6000rpmにて5分間均一化処理し、40℃に冷却後、表2記載の(C)の酸化防止剤と(A)の高度不飽和脂肪酸含有油脂と(B)の酸化防止剤の混合物を添加し、ホモミキサーで7000rpm、30分間均一化処理を行った。得られた乳化物を55℃に加温しながら30mL/minの送液量で入り口温度145℃、アトマイザー回転数30000rpmのスプレードライヤーにフィードし、さらに30メッシュの篩にて分別して実施例9~10、参考例1、比較例6の粉体を得た。
[Preparation Example 3: Preparation of highly unsaturated fatty acid-containing powder (Examples 9 to 10, Reference Example 1 , Comparative Example 6)]
12% by mass of Arabic Coal SS (manufactured by SANEI PHARMACEUTICAL CO., LTD.), 9% by mass of Pine Index #2 (manufactured by Matsutani Chemical Co., Ltd.), and the remaining water excluding the highly unsaturated fatty acid-containing fats and oils (A) and antioxidants shown in Table 2 were heated to 80°C, homogenized for 5 minutes at 6000 rpm using a homomixer, cooled to 40°C, and then a mixture of the antioxidants (C) and the highly unsaturated fatty acid-containing fats and oils (A) and the antioxidants (B) shown in Table 2 was added, and homogenized for 30 minutes at 7000 rpm using a homomixer. The resulting emulsion was fed to a spray dryer with an inlet temperature of 145°C and an atomizer rotation speed of 30,000 rpm at a liquid feed rate of 30 mL/min while being heated to 55°C, and further separated using a 30 mesh sieve to obtain powders of Examples 9 to 10, Reference Example 1 , and Comparative Example 6.
[水溶性評価]
実施例及び比較例の1%水溶液の溶解性を確認し以下の基準で判定した。
◎:希釈後速やかに均一に溶解
○:希釈後撹拌が必要であるが均一に溶解
△:撹拌によって一部は溶解するが溶け残りや沈殿が存在
×:溶解しない
[Water solubility evaluation]
The solubility of 1% aqueous solutions of the Examples and Comparative Examples was confirmed and judged according to the following criteria.
◎: Dissolves quickly and uniformly after dilution. ○: Requires stirring after dilution, but dissolves uniformly. △: Partially dissolves with stirring, but remains undissolved or precipitate remains. ×: Does not dissolve.
[過酸化物価評価]
製剤から油分を抽出後、基準油脂分析法の電位差滴定法に準じ、888 Titrando(メトローム社製)にて過酸化物価(POV)を測定し、所定のPOVに到達する日数を確認した。
[Peroxide value evaluation]
After extracting the oil from the preparation, the peroxide value (POV) was measured using 888 Titrando (Metrôm) in accordance with the potentiometric titration method of the standard method for the analysis of fats and oils, and the number of days required to reach the specified POV was confirmed.
表1から明らかなように、実施例1~5は極めて良好な水溶性を示すと共に、比較例1~3と比べてPOVが10に到達する日数が明らかに延長された。 As is clear from Table 1, Examples 1 to 5 exhibited extremely good water solubility, and the number of days required for the POV to reach 10 was significantly extended compared to Comparative Examples 1 to 3.
表2から明らかなように、調製例2で得られた実施例6~8の粉体は極めて良好な水溶性を示すと共に、比較例4、5と比べてPOVが30に到達する日数が明らかに延長された。また、調製例3で得られた実施例9~10、参考例1の粉体は良好な水溶性を示すと共に、比較例6と比べてPOVが30に到達する日数が明らかに延長された。 As is clear from Table 2, the powders of Examples 6 to 8 obtained in Preparation Example 2 exhibited extremely good water solubility, and the number of days until the POV reached 30 was clearly extended compared to Comparative Examples 4 and 5. In addition, the powders of Examples 9 to 10 and Reference Example 1 obtained in Preparation Example 3 exhibited good water solubility, and the number of days until the POV reached 30 was clearly extended compared to Comparative Example 6.
Claims (8)
(B)(b1)フェノール性水素を有する油溶性のラジカル捕捉型酸化防止剤及び(b2)酸化-還元型を示す油溶性の酸化防止剤と、
(C)(c1)フェノール性水素を有する水溶性のラジカル捕捉型酸化防止剤及び/又は(c2)酸化-還元型を示す水溶性の酸化防止剤(但し、アスコルビン酸、エリソルビン酸を除く。)とを含有する高度不飽和脂肪酸含有水溶性製剤であって、
(A)の含有量が10質量%~40質量%、(B)及び(C)の合計含有量が0.01質量%~10質量%であり、(B)/(C)の比率が0.67~5であり、((b1)+(c1))/((b2)+(c2))の比率が0.2~5であり、
(c2)が、アスコルビン酸金属塩、エリソルビン酸金属塩のうちの1種又は2種以上であることを特徴とする高度不飽和脂肪酸含有水溶性製剤。 (A) a highly unsaturated fatty acid or an oil or fat containing a highly unsaturated fatty acid;
(B) (b1) an oil-soluble radical scavenging antioxidant having a phenolic hydrogen atom and (b2) an oil-soluble antioxidant exhibiting an oxidation-reduction type,
(C) A highly unsaturated fatty acid-containing water-soluble preparation containing (c1) a water-soluble radical-scavenging antioxidant having a phenolic hydrogen atom and/or (c2) a water-soluble antioxidant exhibiting an oxidation-reduction type (excluding ascorbic acid and erythorbic acid),
the content of (A) is 10 % by mass to 40 % by mass, the total content of (B) and (C) is 0.01% by mass to 10% by mass, the ratio of (B)/(C) is 0.67 to 5, and the ratio of ((b1)+(c1))/((b2)+(c2)) is 0.2 to 5;
A highly unsaturated fatty acid-containing water-soluble preparation, wherein (c2) is one or more of a metal salt of ascorbic acid and a metal salt of erythorbic acid .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020132805A JP7473960B2 (en) | 2020-08-05 | 2020-08-05 | Water-soluble preparations containing highly unsaturated fatty acids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020132805A JP7473960B2 (en) | 2020-08-05 | 2020-08-05 | Water-soluble preparations containing highly unsaturated fatty acids |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022029516A JP2022029516A (en) | 2022-02-18 |
JP7473960B2 true JP7473960B2 (en) | 2024-04-24 |
Family
ID=80324938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020132805A Active JP7473960B2 (en) | 2020-08-05 | 2020-08-05 | Water-soluble preparations containing highly unsaturated fatty acids |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7473960B2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004048496A1 (en) | 2002-11-22 | 2004-06-10 | Nippon Suisan Kaisha, Ltd. | Composition containing organic substance having double bond with improved oxidation stability |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06298642A (en) * | 1993-04-14 | 1994-10-25 | Japan Tobacco Inc | O/w type emulsion containing highly unsaturated fatty acid and method for preventing oxidation thereof |
JP3596059B2 (en) * | 1994-12-08 | 2004-12-02 | 日本油脂株式会社 | Fatty oil emulsified composition containing highly unsaturated fatty acids |
JP3542054B2 (en) * | 1995-10-20 | 2004-07-14 | 長谷川香料株式会社 | Antioxidants for docosahexaenoic acids |
JPH09272892A (en) * | 1996-04-04 | 1997-10-21 | Nippon Synthetic Chem Ind Co Ltd:The | Lipid composition containing docosahexaenoic acid |
-
2020
- 2020-08-05 JP JP2020132805A patent/JP7473960B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004048496A1 (en) | 2002-11-22 | 2004-06-10 | Nippon Suisan Kaisha, Ltd. | Composition containing organic substance having double bond with improved oxidation stability |
Also Published As
Publication number | Publication date |
---|---|
JP2022029516A (en) | 2022-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105636450B (en) | Oil and fat containing polyvalent unsaturated fatty acid | |
JP6964660B2 (en) | Antioxidant dispersion | |
JP5979726B2 (en) | Edible emulsion | |
CN108713053A (en) | Inhibited oil oil/fat composition | |
US9725675B2 (en) | Lipid-soluble formulations containing mixtures of antioxidants | |
JP6870220B2 (en) | Polyunsaturated fatty acid-containing plastic fat composition | |
JP2008163202A (en) | Method for inhibiting discoloration of fat-and-oil incorporated with catechin | |
JP6689042B2 (en) | Acid oil-in-water emulsion food | |
JP5765476B2 (en) | Edible vegetable oil containing polyunsaturated fatty acids | |
JP6935818B2 (en) | Fats and oils compositions containing unsaturated fatty acids | |
JP6694726B2 (en) | O / D type emulsion composition, oil-in-water type emulsion composition, food and drink and food material | |
JP7473960B2 (en) | Water-soluble preparations containing highly unsaturated fatty acids | |
US20220167641A1 (en) | Ice cream containing polyunsaturated fatty acids | |
JP7018771B2 (en) | Powdered fats and oils and manufacturing method of powdered fats and oils | |
JP3561571B2 (en) | Antioxidant preparation | |
JP6421252B2 (en) | Oil composition and method for inhibiting oxidation of oil | |
US20230250360A1 (en) | Unsaturated fatty acid-containing water-in-oil type composition and method for producing same | |
JP6704485B1 (en) | Frozen dessert containing highly unsaturated fatty acids | |
JP2021180649A (en) | Plastic oil-and-fat composition containing dha and epa and method for producing the same | |
WO2012014903A1 (en) | Fat-containing composition and oral formulation containing same | |
JP7151979B1 (en) | Antioxidant composition and edible oil | |
JP2023040841A (en) | Antioxidant formulation | |
JP2024109803A (en) | Preparations containing poorly water-soluble substances | |
JP2022088160A (en) | Oil-in-water emulsion composition | |
JP2018139553A (en) | Water-in-oil emulsified oil and fat composition and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20210129 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20210209 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230222 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231108 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231115 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240110 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240327 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240405 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7473960 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |